OJEMDA (TOVORAFENIB)
100 mg/1 · Film-Coated Tablet
By Day One Biopharmaceuticals, Inc.
- NDC
- 82950-001
- Route
- Oral
- Therapeutic class
- Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor , Type II RAF Kinase Inhibitors [MoA]
- Marketing category
- NDA
Package sizes
- 4 BLISTER PACK in 1 CARTON (82950-001-16) / 4 TABLET, FILM COATED in 1 BLISTER PACK (82950-001-04)NDC 82950-001-16Available to order
- 4 BLISTER PACK in 1 CARTON (82950-001-20) / 5 TABLET, FILM COATED in 1 BLISTER PACK (82950-001-05)NDC 82950-001-20Available to order
- 4 BLISTER PACK in 1 CARTON (82950-001-24) / 6 TABLET, FILM COATED in 1 BLISTER PACK (82950-001-06)NDC 82950-001-24Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Oncology & Specialty
See all →Verzenio (abemaciclib)
50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
150 mg/1 · Tablet
Eli Lilly and Company
Available to source
